通達集團(00698.HK)年度純利3.51億港元 同比減少12.5%
格隆匯3月5日丨通達集團(00698.HK)發佈公吿,截至2020年12月31日止年度,公司收入97.59億港元,同比增長6.2%;毛利17.1億港元,同比增長2%;公司擁有人應占純利3.51億港元,同比減少12.5%;每股盈利5.42港仙。
毛利率比去年同期下降約0.8個百分點,從2019年約18.3%降至本年度約17.5%。2020年上半年,全球多個國家採取了大規模的封鎖和檢疫措施,給集團業務帶來了負面影響。隨着本年度下半年封城措施和嚴格的檢疫措施遂步放鬆,集團的業務逐步回升。因此,集團的毛利率僅比去年同期下滑約0.8個百分點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.